Chongqing Genrix Biopharmaceutical Co., Ltd.SSE: 688443

Announcement on Voluntary Disclosure on the Acceptance of Conditional Listing Application for GR1803 Injection

· Issued by Chongqing Genrix Biopharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 2 pages · Chinese

Summary by 6ix AI

The application is for a drug intended for adult patients with relapsed or refractory multiple myeloma who have undergone at least three lines of treatment.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Voluntary Disclosure on the Acceptance of Conditional Listing Application for GR1803 Injection

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Chongqing Genrix Biopharmaceutical Co., Ltd. on 6ix

Earlier from Chongqing Genrix Biopharmaceutical

Later from Chongqing Genrix Biopharmaceutical

All Chongqing Genrix Biopharmaceutical news releases